Transcript Slide 1
Bone Diseases
Dr Derakhshandeh, PhD
Dominant negative mutations
Dominant negative mutations:
antimorphic mutations
an altered gene product that acts
antagonistically to the wild-type allele
These mutations usually result in an
altered molecular function
(often inactive):
Dominant
or
semi-dominant phenotype
2
Dominant negative mutations
In
humans:
Marfan syndrome is an example of
a dominant negative mutation
occurring in an autosomal dominant
disease
the defective glycoprotein product
of the fibrillin gene (FBN1):
antagonizes the product of the
normal allele
3
Marfan syndrome
Fibrillin gene
4
Osteogenesis
imperfecta
5
Osteogenesis imperfect
6
Definition
Osteogenesis imperfecta:
a congenital (present from birth)
condition of abnormal fragility of
the bones
7
Collagen
Fibrillin in EM
8
Collagen
in most tissues and organs
is most plentiful in:
dermis
Tendon
Cartilage
and bone
as a scaffolding for our bodies
Controls cell shape
broken bones regenerate
and wounds heal
9
Collagens
the
fibrous protein constituent:
Insoluble
extracellular
glycoprotein
found in all animals
the most abundant proteins in the human
body
10
Primary Structure of
Collagens
The basic unit of collagens:
a polypeptide consisting of the
repeating sequence
(Glycine (Gly) - X - Y)n
X is often Proline (Pro)
and Y is often hydroxyproline
11
Procollagen Type I
The
most common form of fibrillar
collagen
It is a major constituent of:
bone
and skin
consists of a heterotrimer of:
two alpha1(I)
and one alpha2(I) chains
12
Tertiary Structure
13
Extracellular processes of collagen
synthesis
Prockop & Kivirikko (1984)
14
OI,
Genetic
TYPE I
OSTEOGENESIS IMPERFECTA
WITH BLUE SCLERA
Gene
map locus 17q21.31-q22, 7q22.1
OI
type I phenotype can be produced
by mutation in either the COL1A1 gene
or the COL1A2 gene
15
Osteogenesis imperfecta
type I
1:10 000
dominantly inherited (AD)
Connective tissue disorder
characterized mainly by bone
fragility
blue sclera
'functional null' alleles of COL1A1 on
chromosome 17
or COL1A2 on chromosome 7
lead to reduced amounts of normal
collagen I
16
What is the official name of the
COL1A1 gene?
The official name of this gene is:
“collagen, type I, alpha 1”
COL1A1 is the gene's official
symbol
17
18
19
20
21
22
Glycine
Serin
23
What conditions are related to
the COL1A1 gene?
Ehles-Donlos syndrome (AD)
Arthrochalasia:
(Short stature, Hyper elasticity of skin, AR,
Problem with healing, N-Terminal defect
caused by mutations in the COL1A1/2 gene
24
Arthrochalasia
25
–The mutations in the COL1A1/2 gene
–instruct the cell to leave out a part of
the pro-alpha1(I) chain that contains a
segment used to attach one molecule to
another
–When this part of the protein is missing,
the structure of type I collagen is
compromised
–Tissues that are rich in type I collagen:
•such as the skin, bones, and tendons,
are affected by this change
26
OI Type I
Osteogenesis
imperfecta is the most
common disorder
Mutations:
inactivate one of the two copies
of the COL1A1/2 gene:
27
OI Type I
•The mutated copy of the gene
does not produce any proalpha1/2(I) collagen chains
•Because only one copy of the
gene:
•cells from people with this
disorder make only half of the
normal amount of type I collagen:
•which results in bone fragility
and other symptoms
28
OI Type II
- caused by mutations in the COL1A1/2 gene
Many
different types of mutations in
the COL1A1/2 gene: can cause
osteogenesis imperfecta type II
These mutations range:
from missing pieces of the COL2A1/2
gene
to amino acid substitutions
in which the amino acid glycine is
replaced by another amino acid in the
protein strand
C-terminal
29
OI Type II
Sometimes
one end of the gene
(called the C-terminus) is altered
which interferes with the
association of the protein strands
All of these changes prevent the
normal production of mature type
I collagen
which results in this severe
condition, type II osteogenesis
imperfecta
30
OI Type III
-
caused by mutations in the COL1A1/2 gene
Mutations in the COL1A1/2 gene may result:
unusable for collagen production
Other mutations cause the amino acid glycine
to be replaced by a different amino acid in
the pro-alpha1(I) chain
inhibits the essential interaction between
protein chains
31
type III osteogenesis
imperfecta
inability of the altered procollagen
strands
These alterations negatively affect
tissues that are rich in type I
collagen
such as the skin, bones, teeth
(Dentinogenesis imperfecta), and
tendons
32
OI Type (IV)
caused by mutations in the COL1A1/2 gene
Several different types of mutations in the
COL1A1/2 gene cause osteogenesis imperfecta
type IV
missing pieces of the COL1A1/2 gene
or changes in base pairs
formation of the mature triple-stranded
collagen molecule
33
OI
Position effect (5’/3’- Mutation)
Protein effect (Gly)
Chain effect (aI/aII)
34
Where is the COL1A1 gene
located?
Cytogenetic Location: 17q21.3-q22.1
Molecular Location on chromosome
17
35
CLINICAL FEATURES
Osteogenesis imperfecta:
Characterized
chiefly by
multiple bone fractures, usually
resulting from minimal trauma
Affected
individuals have blue
sclerae, normal-near normal
teeth, and normal or nearnormal stature
36
CLINICAL FEATURES
Osteogenesis imperfecta:
Fractures are rare in the neonatal
period;
fracture tendency is constant from
childhood to puberty
Often increases following menopause in
women and after the sixth decade in
men
37
CLINICAL
FEATURES
OI
38
CLINICAL FEATURES
Fractures:
heal
rapidly with evidence of a
callus formation
and, with good orthopedic care,
without deformity
Hearing loss;
occurs in about 50% of families
beginning in the late teens
to profound deafness, by the end
of the fourth to fifth decade
39
CLINICAL FEATURES
Radiologically:
wormian
bones are common
but bone morphology is
generally normal at birth
Vertebral body morphology:
in the adult is normal initially
but often develops the classic
'cod-fish' appearance
40
EYES
Individuals
with OI type I have
distinctly blue sclera which
remain intensely blue
throughout life
The
intensity of the blue fades
with time: that these
individuals may have sclerae of
normal hue by adult life
41
EYES
Hartikka
et al. (2004) found that:
patients
with COL1A1 mutations
more frequently had blue sclerae
than those with COL1A2 mutations
42
CARDIOVASCULAR
Mitral
valve prolapse occurred
in 18% (3 times the prevalence
in unaffected relatives)
43
In
EARS
likely heterogeneous groups of
patients with OI:
about half of affected individuals
have hearing loss
that begins during the second decade
as a conductive loss
Audiometry
showed hearing loss in 25
patients (59.5%)
44
EARS
Hartikka et al. (2004) reported:
No
correlation was found between
the mutated gene or mutation type
and hearing pattern
The
authors interpreted this to
mean that the basis of hearing loss
in OI is complex
and
that it is a result of
multifactorial
45
Causes, incidence, and risk
factors
All
four types of OI are caused by
defects in the amount or
structure
of Type 1 collagen
an
important part of the bone
matrix
46
Causes, incidence, and risk
factors
The defect may be inherited in an
autosomal dominant pattern from an
affected parent
This means that an affected parent,
who carries a single gene for the
disorder
has a 50% chance of having children
with the disorder
Any child who inherits this gene will be
affected
47
Prevention
Genetic
counseling:
is recommended for prospective
parents if one or both are
affected by this disorder
48
Symptoms
OI:
•
•
•
•
all of the bones are abnormally weak
The severity of the abnormality varies
enormously from Type II OI
which is usually lethal in infancy (or even
before birth)
Type I OI, which may be so mild that the
diagnosis is not made, even in adulthood
49
Symptoms
•
•
•
•
The three classic symptoms of
OI includes:
fragile bones
early hearing loss
and whites of the eyes that
appear bluish (blue sclerae)
50
Symptoms
•
not all people with OI will have
blue sclerae or hearing loss
All do have fragile bones, but not
all people with OI actually ever
break a bone
penetrance of hearing loss is
clearly age-dependent (Garretsen
and Cremers, 1991)
•
51
SKIN
Skin
elasticity
OI type I increased elasticity
in comparison to the type III
patients
52
INHERITANCE
Paternal age effect:
for increased risk of new mutations has
been documented
although it appears to be considerably
lower than, for example, in
Achondroplasia
Blumsohn et al. (2001) confirmed the
presence of a small paternal age effect in
apparently sporadic OI
53
CLINICAL
FEATURES
OII
54
OSTEOGENESIS
IMPERFECTA
CONGENITA,
NEONATAL LETHAL FORM
OSTEOGENESIS IMPERFECTA,
TYPE II
OI
Gene map locus 17q21.31-q22, 7q22.1
55
OSTEOGENESIS IMPERFECTA,
TYPE II
56
Osteogenesis imperfecta, type II:
the most severe form of the disorder
Infants with the disorder:
have soft, fragile bones that may appear
bent or crumpled
Bones are easily broken
and multiple fractures can occur even
before birth
The chest is narrow
with short ribs and underdeveloped lungs
57
Osteogenesis imperfecta, type II
Affected infants:
have short bowed
arms and legs; and
unusually soft skull bones
Characteristic
facial features include a
small, narrow nose and a dark blue tint to
the part of the eyeball that is usually white
Most infants with this condition are stillborn
or die shortly after birth, usually from
respiratory problems. A few children have
lived from several months to a few years
58
CLINICAL
FEATURES
OIII
59
OSTEOGENESIS IMPERFECTA,
TYPE IIIOI
Gene
map locus 17q21.31-q22, 7q22.1
The
causative mutation in most
cases lies in one of the genes for
type I collagen, COL1A1 or COL1A2
60
TYPE III OI
61
TYPE III OI
People with the disorder are much shorter than
average
because the condition prevents bones from
growing normally.
Spinal curvature (scoliosis)
and bone abnormalities often become
progressively worse during childhood
but tend to stabilize during adolescence
These complications may shorten a person's
lifespan by affecting heart and lung function
Other signs and symptoms include a light blue
tint to the part of the eyeball that is usually
white , brittle and discolored teeth, loose
joints, and, in some cases, hearing loss.
62
Gene Therapy
Chamberlain
et al. (2004)
used adeno-associated virus
vectors
to disrupt mutant COL1A1 collagen
genes
in mesenchymal stem cells, from
individuals with severe OI
demonstrating successful gene
targeting in adult human stem cells
63
CLINICAL
FEATURES
OI IV
64
OSTEOGENESIS
IMPERFECTA, TYPE IV
OI, TYPE IV
OSTEOGENESIS IMPERFECTA WITH
NORMAL SCLERAE
Gene map locus 17q21.31-q22
65
OSTEOGENESIS
IMPERFECTA, TYPE
IV
66
Hypothesis
more
than one broken bone occurring in a
single episode (multiple)
present at birth
occuring after only minor trauma
a minority of people with OI never break
a bone
deformed or short extremities (such as
leg deformities or arm deformities)
deafness (conductive hearing loss may
occur in adults)
67
Hypothesis
Short
stature
tooth abnormalities
low nasal bridge
easy bruising
bowed legs
68
Signs and tests
A physical examination may confirm the
presence of fractures, deformities, and
other symptoms.
Bone X-rays may show multiple healed
fractures.
Once the specific molecular diagnosis is
known, family members can be tested
by a DNA blood test.
DNA testing on prenatal chorionic
villus samples (CVS) can make the
diagnosis during pregnancy.
Severe OI is visible on prenatal
69
Osteomyelitis
70
Osteomyelitis
Procedure
Osteomyelitis is an acute or chronic
bone infection, usually caused by
bacteria or by fungus
71
Causes, incidence, and risk
factors Osteomyelitis
The
infection that causes
osteomyelitis:
often is in another part of the body
and spreads to the bone via the blood
Affected bone may have been
predisposed to infection because of
recent trauma
In children:
the long bones are usually affected
In adults:
the vertebrae and the pelvis (hip) are
72
Osteomyelitis
Risk factors are recent trauma, diabetes,
hemodialysis, and intravenous drug abuse.
People who have had their spleen removed
are also at higher risk for osteomyelitis
The incidence of osteomyelitis is 2 in
10,000 people.
73
Prevention
Prompt
and complete treatment of
infections is helpful
High-risk
people should see a
health care provider promptly if
they have signs of an infection
anywhere in the body
74
Symptoms
Pain
in the bone
Local swelling
redness
and warmth
Fever
General discomfort,
uneasiness, or ill feeling
75
Achondroplasia
76
Achondroplasia
Definition
An
inherited disorder of bone
growth
that causes the most common type
of dwarfism
77
Achondroplasia
its characteristic normal to largesized head
shortened arms and legs
(especially the upper arm)
a normal-sized trunk
and waddling gait
78
Achondroplasia
Achondroplasia is inherited as an (AD)
trait
However, the majority of cases,
approximately 80%, appear as
spontaneous mutations
If one parent has Achondroplasia, the
infant has a 50% chance of inheriting
the disorder
If both parents have the condition, the
infant's chances of being affected
increase to 75%
79
Genetics of Achondroplasia
99% of the affected individuals:
a single point mutation
in the Fibroblast Growth Factor
Receptor gene3 (FGFR 3)
located on chromosome 4
glycine is substituted for arginine at
codon 380 of FGFR 3
80
Such
a mutation results:
in an abnormal cartilage and
fibrous connecting tissue formation
Therefore, not only bones, but the
ligaments, tendons and muscles of
the patient with Achondroplasia are
affected
81
Family with compound heterozygosity
for N540K and G380R mutations
82
Prevention
Genetic
counseling may be helpful
for prospective parents:
when one or both have
achondroplasia
Because achondroplasia arises as a
spontaneous mutation:
absolute prevention is not
possible
83
Symptoms
at birth:
Short stature
short limbs
large appearing head
Skeletal (limb) abnormality
Abnormal hand appearance
with persistent space between the long and
ring fingers
marked kyphosis and lordosis (spine
curvatures)
84
kyphosis and lordosis
85
Symptoms
Waddling gait
prominent forehead (frontal bossing)
increased inward curve of lower back
increased outward curve of upper back
making back appear slightly hunched
(kyphosis)
head appears disproportionately large for
body
bowed legs
86